Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Blood proteins predict the risk of developing more than 60 diseases, claims study Dr. Kamal Kant Kohli25 July 2024 3:30 AM ISTResearch on thousands of proteins measured from a drop of blood demonstrates the ability of proteins to predict the onset of many diverse diseases. ...
Lupin alliance partner ForDoz gets USFDA nod for Doxorubicin Hydrochloride Liposome Injection Ruchika Sharma23 July 2024 1:20 PM ISTMumbai: Global pharma major Lupin Limited has announced that its alliance partner, ForDoz Pharma Corporation, USA has received approval from the...
Blenrep combinations in multiple myeloma application accepted for review by EMA: GSK Ruchika Sharma20 July 2024 3:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for...
CDSCO Panel Denies Pfizer Products India request for local CT waiver to market Elranatamab solution for injection Dr. Divya Colin26 Jun 2024 6:00 PM ISTNew Delhi: Noting that no new data, literature, or updates have been presented by the firm, the Subject Expert Committee (SEC) functional under the...
Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma Ruchika Sharma27 May 2024 11:30 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
USFDA approves Gland Pharma Plerixafor Injection Ruchika Sharma7 May 2024 1:30 PM ISTHyderabad: Generic injectable-focused pharmaceutical company, Gland Pharma Limited, has received approval from the United States Food and Drug...
CDSCO panel rejects Pfizer Products India Local Clinical Trial Waiver Proposal for Elranatamab solution for injection Dr. Divya Colin27 April 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by Pfizer Products India for grant of permission to import and market Elranatamab solution for injection...
USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy Ruchika Sharma7 April 2024 10:00 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene...
Bristol Myers Squibb Abecma approved in European Union for triple-class exposed relapsed and refractory multiple myeloma Ruchika Sharma22 March 2024 4:02 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Abecma (idecabtagene vicleucel;...
Need More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: Citing that more justification is required, the Subject Expert Committee SEC functional under the Central Drug Standard Control...
